Harrow, Inc. Gain (Loss) on Disposition of Assets
Harrow, Inc. (HROW) reported Gain (Loss) on Disposition of Assets of $168.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-03-27
- Harrow, Inc. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was $159.00K.
- Harrow, Inc. gain (loss) on disposition of assets for the quarter ending 2020-12-31 was $46.00K, a 98.82% decline year-over-year.
- Harrow, Inc. gain (loss) on disposition of assets for the quarter ending 2020-09-30 was $0.00.
- Harrow, Inc. gain (loss) on disposition of assets for the quarter ending 2019-12-31 was $3.90M.
- Harrow, Inc. gain (loss) on disposition of assets for fiscal 2023 was $168.00K, a 143.48% increase from fiscal 2022.
- Harrow, Inc. gain (loss) on disposition of assets for fiscal 2022 was $69.00K, a 68.29% increase from fiscal 2021.
- Harrow, Inc. gain (loss) on disposition of assets for fiscal 2021 was $41.00K, a 0.00% change from fiscal 2020.
- Harrow, Inc. gain (loss) on disposition of assets for fiscal 2020 was $41.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 9 month as first filed | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | $168.00K 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $159.00K 10-Q · filed 2023-11-13 | |||||
| 2022-12-31 | $69.00K 10-K · filed 2024-03-19 | $99.00K 10-K · filed 2023-03-23 | ||||
| 2021-12-31 | $41.00K 10-K · filed 2023-03-23 | |||||
| 2020-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $46.00K derived: sum of 2 quarters · filed 2022-03-10 | $41.00K 10-K · filed 2022-03-10 | -$105.00K 10-K · filed 2021-03-08 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$5.00K 10-Q · filed 2021-11-09 | ||||
| 2020-06-30 | -$5.00K 10-Q · filed 2021-08-10 | |||||
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$32.00K derived: sum of 2 quarters · filed 2021-03-08 | -$112.00K derived: sum of 3 quarters · filed 2021-03-08 | -$108.00K 10-K · filed 2021-03-08 | -$4.15M 10-K · filed 2020-03-13 | |
| 2019-09-30 | -$3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$4.02M derived: sum of 2 quarters · filed 2020-08-10 | -$4.01M 10-Q · filed 2019-11-13 | -$4.01M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$76.00K 10-Q · filed 2020-08-10 | -$76.00K derived: sum of 3 quarters · filed 2020-08-10 | -$76.00K derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-11 | $4.00K derived: sum of 2 quarters · filed 2020-05-11 | $4.00K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | -$393.00K 10-K · filed 2020-03-13 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$393.00K 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | -$393.00K 10-Q · filed 2019-08-14 | |||||
| 2017-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$181.00K derived: sum of 2 quarters · filed 2019-03-12 | -$339.00K derived: sum of 3 quarters · filed 2019-03-12 | -$354.00K 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$200.00K derived: sum of 2 quarters · filed 2018-11-13 | -$215.00K 10-Q · filed 2018-11-13 | -$326.00K 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | -$158.00K 10-Q · filed 2017-08-10 | -$173.00K 10-Q · filed 2018-08-06 | ||||
| 2017-03-31 | -$15.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |